Lupin Invests $250 Million in New Coral Springs Manufacturing Facility
Lupin, a global generics maker, is constructing a state-of-the-art pharma manufacturing facility in Coral Springs, FL, with an investment of approximately $250 million.
The new site will produce over 25 critical respiratory medicines, including albuterol inhalers for children with asthma and service members.
- Create over 200 jobs in the Broward County area by 2030
- Boost local manufacturing and supply chain diversification
- Strengthen domestic manufacturing and drug security
The new plant will manufacture critical respiratory meds, including albuterol inhalers for children with asthma and service members.
Lupin's investment will total approximately $250 million over five years, including research & development, infrastructure, and capital expenses.
Author's summary: Lupin invests $250 million in a new manufacturing facility.